quantifying expectations, page-42

Some additional info on Dr Quirk's fellow presenters in the "Technology Showcase" segment at the upcoming PPP Conference to be held in France next month:

Technology Showcase

Chair: Adam Watkinson

13:45 MRI induced RF heating of transdermal patches
Ryan Gordon Minnesota, USA

14:00 Microneedle-based delivery of biologics, vaccines
and topical therapeutics
Ryan Gordon, Minnesota, USA

14:15 Enhanced microneedle delivery by magnetic microarrays
Christopher Quirk, Perth, Australia

14:30 Development of an abuse deterrent transdermal buprenorphine system for the treatment of opioid abuse and pain
Philip Fowler, Lexington, KY, USA

14.45 Strat-M membrane: a synthetic model for studying in-vitro diffusion in the transdermal arena
Vivek Joshi, Danvers, USA
___

Adam Watkinson - Pharmaceutical Development Consultant UK & Director at Storith Consulting Limited

Dr Watkinson also co-authored Topical and Transdermal Drug Delivery with OBJ SAB member, Dr Heather Benson and played a pivotal role in the development and approval of Axiron®, Acrux transdermal testosterone product licensed to and launched by Eli Lilly

Ryan Gordon - Global Business Manager at 3M

Christopher Quirk - Medical Director at OBJ Limited

Philip Fowler - Project Manager and Formulations Scientist located in Lexington (Although Dr Fowler's profile doesn't confirm his current employer 3M do have a large facility located in Lexington)

Vivek Joshi - Chief Business Head at Sundyota Numandis Pharmaceuticals Pvt Ltd

"With over 600 employees & 21 distribution centers across the nation reaching over 80,000 retailers, Sundyota Numandis is amongst one of the fastest-growing pharmaceutical companies today with a proven track record of success. Headquartered in Ahmedabad, Gujarat in India with a network throughout India, Sundyota Numandis works with some of the top-ranked pharmaceutical companies from around the globe to bring together breakthrough product innovations, from probiotics to nutraceuticals and way beyond."

Sundyota Numandis Pharmaceuticals Pvt Ltd
___

Names amongst the other presenting speakers who OBJ have already collaborated with:

Keith Brain, Cardiff, UK
Chris Anderson, Sweden
Michael Roberts, Australia

PPP Conference
___

Topical and Transdermal Drug Delivery - Part 1 - Dr Heather Benson
___

This 2008 article on Zinc Oxide also caught my attention today, but not so much in the content of the abstract, but more so the names of OBJ collaborating scientist Dr Roberts co-authors as both Dr Nohynek and Dr Dufour work for the Worldwide Safety Evaluation Division of L’Oreal Research and Innovation

Nanotechnology, Cosmetics and the Skin:
Nohynek GJ, Dufour EK, Roberts MS

Skin Institute - NZ